Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-14

FDA Approved: DICLOFENAC POTASSIUM — Original Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a generic diclofenac potassium tablet from Taro Pharmaceuticals U.S.A., Inc. under an original ANDA for relief of pain in several conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DICLOFENAC POTASSIUM (diclofenac potassium)

Snippet

ORIG AP for DICLOFENAC POTASSIUM (DICLOFENAC POTASSIUM)